Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2005 Jul;90(4):F294–F300. doi: 10.1136/adc.2004.056317

Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis

E Nestaas, H Bangstad, L Sandvik, K Wathne
PMCID: PMC1721925  PMID: 15857879

Abstract

Objectives: To review the evidence from controlled clinical trials of neonates given equal daily aminoglycoside doses as extended interval dosing (dosage interval typically 24 hours in term and 36–48 hours in immature neonates) compared with traditional dosing (dosage interval typically 8–12 hours in term and 12–24 hours in immature neonates).

Design: Systematic review and meta-analysis of controlled trials found in electronic databases, trial registers, and references in reviews and selected trials.

Settings: The selected trials were blinded and assessed for methodological quality. Each trial's own predefined criteria for treatment failure, nephrotoxicity, ototoxicity, and therapeutic serum drug concentrations were used.

Subjects: Controlled trials of neonatal aminoglycoside treatment in which equal aminoglycoside daily doses were given at traditional and extended dosage intervals.

Main outcome measures: Serum drug concentrations outside the therapeutic range. Treatment failure and toxicity.

Results: Sixteen trials involving 823 neonates met the inclusion criteria for the systematic review. Twelve trials involving 698 neonates were included in the meta-analysis of the pharmacokinetics. Compared with traditional dosing, extended interval dosing was associated with a significantly lower risk of both peak (summary risk ratio 0.50, 95% confidence interval 0.26 to 0.94) and trough (0.36, 0.25 to 0.56) serum drug concentrations outside the therapeutic range. Accurate information on treatment failure was obtained in nine trials involving 555 neonates. One trial reported treatment failure. In this trial two neonates in the traditional dosing group did not respond to treatment within 72 hours. Nephrotoxicity was investigated in 589 neonates in 12 trials and ototoxicity in 210 neonates in four trials, with no significant differences between the two dosing regimens.

Conclusions: Extended interval dosing of aminoglycosides in neonates is safe and effective, with a reduced risk of serum drug concentrations outside the therapeutic range.

Full Text

The Full Text of this article is available as a PDF (106.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal Ghanshyam, Rastogi Alok, Pyati Suma, Wilks Angela, Pildes Rosita S. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g. J Perinatol. 2002 Jun;22(4):268–274. doi: 10.1038/sj.jp.7210704. [DOI] [PubMed] [Google Scholar]
  2. Ali M. Z., Goetz M. B. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997 May;24(5):796–809. doi: 10.1093/clinids/24.5.796. [DOI] [PubMed] [Google Scholar]
  3. Alsaedi Saad A. Once daily gentamicin dosing in full term neonates. Saudi Med J. 2003 Sep;24(9):978–981. [PubMed] [Google Scholar]
  4. Aust G. Vestibulotoxicity and ototoxicity of gentamicin in newborns at risk. Int Tinnitus J. 2001;7(1):27–29. [PubMed] [Google Scholar]
  5. Bailey T. C., Little J. R., Littenberg B., Reichley R. M., Dunagan W. C. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997 May;24(5):786–795. doi: 10.1093/clinids/24.5.786. [DOI] [PubMed] [Google Scholar]
  6. Barclay M. L., Begg E. J. Aminoglycoside adaptive resistance: importance for effective dosage regimens. Drugs. 2001;61(6):713–721. doi: 10.2165/00003495-200161060-00001. [DOI] [PubMed] [Google Scholar]
  7. Barza M., Ioannidis J. P., Cappelleri J. C., Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 1996 Feb 10;312(7027):338–345. doi: 10.1136/bmj.312.7027.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Begg E. J., Peddie B. A., Chambers S. T., Boswell D. R. Comparison of gentamicin dosing regimens using an in-vitro model. J Antimicrob Chemother. 1992 Apr;29(4):427–433. doi: 10.1093/jac/29.4.427. [DOI] [PubMed] [Google Scholar]
  9. Berlin J. A., Laird N. M., Sacks H. S., Chalmers T. C. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989 Feb;8(2):141–151. doi: 10.1002/sim.4780080202. [DOI] [PubMed] [Google Scholar]
  10. CAMPBELL D. T. Factors relevant to the validity of experiments in social settings. Psychol Bull. 1957 Jul;54(4):297–312. doi: 10.1037/h0040950. [DOI] [PubMed] [Google Scholar]
  11. Chotigeat U., Narongsanti A., Ayudhya D. P. Gentamicin in neonatal infection: once versus twice daily dosage. J Med Assoc Thai. 2001 Aug;84(8):1109–1115. [PubMed] [Google Scholar]
  12. Contopoulos-Ioannidis Despina G., Giotis Nikos D., Baliatsa Dimitra V., Ioannidis John P. A. Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics. 2004 Jul;114(1):e111–e118. doi: 10.1542/peds.114.1.e111. [DOI] [PubMed] [Google Scholar]
  13. Cucherat M., Boissel J. P., Leizorovicz A., Haugh M. C. EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed. 1997 Jul;53(3):187–190. doi: 10.1016/s0169-2607(97)00016-3. [DOI] [PubMed] [Google Scholar]
  14. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Egger M., Smith G. D., Phillips A. N. Meta-analysis: principles and procedures. BMJ. 1997 Dec 6;315(7121):1533–1537. doi: 10.1136/bmj.315.7121.1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ferriols-Lisart R., Alós-Almiñana M. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am J Health Syst Pharm. 1996 May 15;53(10):1141–1150. doi: 10.1093/ajhp/53.10.1141. [DOI] [PubMed] [Google Scholar]
  17. Finitzo-Hieber T., McCracken G. H., Jr, Roeser R. J., Allen D. A., Chrane D. F., Morrow J. Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study. Pediatrics. 1979 Mar;63(3):443–450. [PubMed] [Google Scholar]
  18. Galløe A. M., Graudal N., Christensen H. R., Kampmann J. P. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol. 1995;48(1):39–43. doi: 10.1007/BF00202170. [DOI] [PubMed] [Google Scholar]
  19. Gooding N., Elias-Jones A., Shenoy M. Gentamicin dosing in neonatal patients. Pharm World Sci. 2001 Oct;23(5):179–180. doi: 10.1023/a:1012221801816. [DOI] [PubMed] [Google Scholar]
  20. Hatala R., Dinh T. T., Cook D. J. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis. 1997 May;24(5):810–815. doi: 10.1093/clinids/24.5.810. [DOI] [PubMed] [Google Scholar]
  21. Hatala R., Dinh T., Cook D. J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med. 1996 Apr 15;124(8):717–725. doi: 10.7326/0003-4819-124-8-199604150-00003. [DOI] [PubMed] [Google Scholar]
  22. Hayani K. C., Hatzopoulos F. K., Frank A. L., Thummala M. R., Hantsch M. J., Schatz B. M., John E. G., Vidyasagar D. Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr. 1997 Jul;131(1 Pt 1):76–80. doi: 10.1016/s0022-3476(97)70127-6. [DOI] [PubMed] [Google Scholar]
  23. Jüni P., Altman D. G., Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001 Jul 7;323(7303):42–46. doi: 10.1136/bmj.323.7303.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kosalaraksa Pope, Janthep Pakamas, Jirapradittha Junya, Taksaphan Sukanya, Kiatchoosakun Pakaphan. Once versus twice daily dose of gentamicin therapy in Thai neonates. J Med Assoc Thai. 2004 Apr;87(4):372–376. [PubMed] [Google Scholar]
  25. Kotze A., Bartel P. R., Sommers D. K. Once versus twice daily amikacin in neonates: prospective study on toxicity. J Paediatr Child Health. 1999 Jun;35(3):283–286. doi: 10.1046/j.1440-1754.1999.00352.x. [DOI] [PubMed] [Google Scholar]
  26. Krishnan L., George S. A. Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatr. 1997 Dec;34(12):1075–1080. [PubMed] [Google Scholar]
  27. Langhendries J. P., Battisti O., Bertrand J. M., François A., Darimont J., Ibrahim S., Tulkens P. M., Bernard A., Buchet J. P., Scalais E. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity. Dev Pharmacol Ther. 1993;20(3-4):220–230. doi: 10.1159/000457566. [DOI] [PubMed] [Google Scholar]
  28. Lundergan F. S., Glasscock G. F., Kim E. H., Cohen R. S. Once-daily gentamicin dosing in newborn infants. Pediatrics. 1999 Jun;103(6 Pt 1):1228–1234. doi: 10.1542/peds.103.6.1228. [DOI] [PubMed] [Google Scholar]
  29. Mercado Ma Cecilia K., Brodsky Nancy L., McGuire Michael K., Hurt Hallam. Extended interval dosing of gentamicin in preterm infants. Am J Perinatol. 2004 Feb;21(2):73–77. doi: 10.1055/s-2004-820515. [DOI] [PubMed] [Google Scholar]
  30. Moore R. D., Smith C. R., Lietman P. S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis. 1984 Mar;149(3):443–448. doi: 10.1093/infdis/149.3.443. [DOI] [PubMed] [Google Scholar]
  31. Munckhof W. J., Grayson M. L., Turnidge J. D. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother. 1996 Apr;37(4):645–663. doi: 10.1093/jac/37.4.645. [DOI] [PubMed] [Google Scholar]
  32. Novelli A., Mazzei T., Fallani S., Cassetta M. I., Conti S. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. J Chemother. 1995 Aug;7(4):355–362. doi: 10.1179/joc.1995.7.4.355. [DOI] [PubMed] [Google Scholar]
  33. Skopnik H., Wallraf R., Nies B., Tröster K., Heimann G. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child. 1992 Jan;67(1 Spec No):57–61. doi: 10.1136/adc.67.1_spec_no.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Solomon R., Kuruvilla K. A., Job V., Selvakumar R., Jeyaseelan L., Kanagasabapathy A. S., Jana A. K. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatr. 1999 Feb;36(2):133–137. [PubMed] [Google Scholar]
  35. Thureen P. J., Reiter P. D., Gresores A., Stolpman N. M., Kawato K., Hall D. M. Once- versus twice-daily gentamicin dosing in neonates >/=34 Weeks' gestation: cost-effectiveness analyses. Pediatrics. 1999 Mar;103(3):594–598. doi: 10.1542/peds.103.3.594. [DOI] [PubMed] [Google Scholar]
  36. de Alba Romero C., Gómez Castillo E., Manzanares Secades C., Rodriguez López J., Arreaza López L., Saenz Valiente P. Once daily gentamicin dosing in neonates. Pediatr Infect Dis J. 1998 Dec;17(12):1169–1171. doi: 10.1097/00006454-199812000-00017. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only appendix]
archdischfn_adc.2004.056317_index.html (1.1KB, html)
archdischfn_adc.2004.056317_1.pdf (19.8KB, pdf)

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES